VildagliptinDPP-4 Inhibitor (Antidiabetic Preparations) Indication: ViglitaTM is indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus. Dosage & Administration: The recommended dose of ViglitaTM is 50 mg or 100 mg daily for monotherapy; 50 mg twice daily (morning and evening) when used in dual combination with Metformin […]